How effective are the usual treatments for ulcerative colitis?

被引:50
作者
Bebb, JR [1 ]
Scott, BB [1 ]
机构
[1] Lincoln Cty Hosp, Dept Gastroenterol, Lincoln LN2 5QY, England
关键词
D O I
10.1111/j.1365-2036.2004.02018.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Details of the efficacy of the drugs used in ulcerative colitis are not readily available. Methods: We have reviewed all placebo-controlled trials of the commonly used drugs for both induction and maintenance of remission to determine the efficacy and to calculate the numbers needed to treat (NNTs) to achieve a specified benefit for each drug. Results: The drug response rates and the NNTs (with 95% CI) are tabulated for each drug. Conclusion: Corticosteroids give a remission rate of 68% in mild or moderate disease and an NNT for remission of 2 (95% CI 1.4-5) in mild disease. Intravenous hydrocortisone gives a remission rate of 60-73%. Aminosalicylates are relatively ineffective in inducing remission with an NNT of 10 (95% CI 7-21) improving to 8 (95% CI 5-20) if the dose greater than or equal to3 g daily. They are better at maintenance (NNT = 6; 95% CI 4-8). Intravenous ciclosporin is very effective in achieving remission in severe colitis with an NNT of 1.2 (95% CI 1-2.5). Although there is fairly good evidence that azathioprine is effective in maintaining remission and is used widely, there are no suitable placebo-controlled trials to calculate the NNT.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 40 条
[21]   SAFETY AND EFFICACY OF CONTROLLED-RELEASE MESALAMINE FOR MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS [J].
MINER, P ;
HANAUER, S ;
ROBINSON, M ;
SCHWARTZ, J ;
ARORA, S ;
BRIGGS, RL ;
LAWLIS, V ;
FELGER, C ;
KITZMILLER, G ;
LIEBERMANN, T ;
FRACHTMAN, R ;
FISCHER, C ;
CELLO, JP ;
GRENDELL, J ;
SATOW, J ;
HANAUER, SB ;
HANAN, I ;
SCHULTZ, P ;
JAMES, D ;
MERTESDORF, J ;
HIESTAND, F ;
TUCKER, P ;
ROBERTS, T ;
BRUNDAGE, P ;
GRIFFIN, T ;
BECK, JE ;
RICK, G ;
HARTONG, W ;
BUSER, W ;
BRAND, S ;
BRYANT, P ;
KLIEWER, M ;
MELLOW, M ;
MCFADDEN, R ;
NEUMANN, D ;
HELIN, K ;
PRIVETTCOINTEPAS, CJ ;
MEEK, RR ;
ROUFAIL, W ;
BRICE, R ;
HUGHES, TP ;
FINA, M ;
MURPHY, D ;
CLINARD, L ;
ALLMAN, D ;
BOWEN, B ;
SCHWARTZ, JL ;
JURCIK, I ;
WHITE, LB ;
COHEN, M .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (02) :296-304
[22]  
MISIEWICZ JJ, 1965, LANCET, V1, P185
[23]  
PEARSON DC, 2003, COCHRANE LIB
[24]  
RICEOXLEY JM, 1950, LANCET, V258, P663
[25]  
RIIS P, 1973, SCAND J GASTROENTERO, V8, P71
[26]  
ROBINSON M, 1988, GASTROENTEROLOGY, V94, pA381
[27]  
ROSENBERG JL, 1975, GASTROENTEROLOGY, V69, P96
[28]  
Rutgeerts P, 2002, GASTROENTEROLOGY, V122, pA618
[29]   AZODISAL SODIUM IN THE TREATMENT OF ULCERATIVE-COLITIS - A STUDY OF TOLERANCE AND RELAPSE-PREVENTION PROPERTIES [J].
SANDBERGGERTZEN, H ;
JARNEROT, G ;
KRAAZ, W .
GASTROENTEROLOGY, 1986, 90 (04) :1024-1030
[30]  
SANDBORN W, 2003, COCHRANE LIB